These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21695284)

  • 1. Tesamorelin: a novel therapeutic option for HIV/HAART-associated increased visceral adipose tissue.
    Falutz J
    Drugs Today (Barc); 2011 Jun; 47(6):419-30. PubMed ID: 21695284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of a growth hormone-releasing factor in patients with HIV.
    Falutz J; Allas S; Blot K; Potvin D; Kotler D; Somero M; Berger D; Brown S; Richmond G; Fessel J; Turner R; Grinspoon S
    N Engl J Med; 2007 Dec; 357(23):2359-70. PubMed ID: 18057338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.
    Falutz J; Potvin D; Mamputu JC; Assaad H; Zoltowska M; Michaud SE; Berger D; Somero M; Moyle G; Brown S; Martorell C; Turner R; Grinspoon S
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):311-22. PubMed ID: 20101189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.
    Falutz J; Mamputu JC; Potvin D; Moyle G; Soulban G; Loughrey H; Marsolais C; Turner R; Grinspoon S
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4291-304. PubMed ID: 20554713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.
    Stanley TL; Feldpausch MN; Oh J; Branch KL; Lee H; Torriani M; Grinspoon SK
    JAMA; 2014 Jul 23-30; 312(4):380-9. PubMed ID: 25038357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on tesamorelin in HIV-associated lipodystrophy.
    Dhillon S
    BioDrugs; 2011 Dec; 25(6):405-8. PubMed ID: 22050344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.
    Sivakumar T; Mechanic O; Fehmie DA; Paul B
    HIV Med; 2011 Sep; 12(8):453-62. PubMed ID: 21265979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.
    Dhillon S
    Drugs; 2011 May; 71(8):1071-91. PubMed ID: 21668043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation.
    Falutz J; Allas S; Mamputu JC; Potvin D; Kotler D; Somero M; Berger D; Brown S; Richmond G; Fessel J; Turner R; Grinspoon S
    AIDS; 2008 Sep; 22(14):1719-28. PubMed ID: 18690162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone deficiency and human immunodeficiency virus.
    Rochira V; Guaraldi G
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):91-111. PubMed ID: 28477736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy.
    Spooner LM; Olin JL
    Ann Pharmacother; 2012 Feb; 46(2):240-7. PubMed ID: 22298602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.
    Makimura H; Feldpausch MN; Rope AM; Hemphill LC; Torriani M; Lee H; Grinspoon SK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4769-79. PubMed ID: 23015655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.
    Stanley TL; Falutz J; Mamputu JC; Soulban G; Potvin D; Grinspoon SK
    AIDS; 2011 Jun; 25(10):1281-8. PubMed ID: 21516030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV.
    Adrian S; Scherzinger A; Sanyal A; Lake JE; Falutz J; Dubé MP; Stanley T; Grinspoon S; Mamputu JC; Marsolais C; Brown TT; Erlandson KM
    J Frailty Aging; 2019; 8(3):154-159. PubMed ID: 31237318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and HIV infection: contribution to disease manifestations and clinical implications.
    Falutz J
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):517-29. PubMed ID: 21663844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone-releasing factor agonists for the treatment of HIV-associated lipodystrophy.
    Hu M; Tomlinson B
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1143-50. PubMed ID: 20872317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of the growth hormone axis in patients with HIV infection.
    Blackman MR
    N Engl J Med; 2007 Dec; 357(23):2397-9. PubMed ID: 18057344
    [No Abstract]   [Full Text] [Related]  

  • 18. Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
    Fourman LT; Czerwonka N; Feldpausch MN; Weiss J; Mamputu JC; Falutz J; Morin J; Marsolais C; Stanley TL; Grinspoon SK
    AIDS; 2017 Oct; 31(16):2253-2259. PubMed ID: 28832410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TH9507: an experimental treatment for lipodystrophy.
    Monroe A
    BETA; 2007; 19(4):16-9. PubMed ID: 18069152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection, body composition changes and related metabolic complications: contributing factors and evolving management strategies.
    Falutz J
    Curr Opin Clin Nutr Metab Care; 2011 May; 14(3):255-60. PubMed ID: 21460720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.